Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells.

MLA

Farokhi-Fard, Aref, et al. “Anti-IL-1RAP ScFv-MSA-S19-TAT Fusion Carrier as a Multifunctional Platform for Versatile Delivery of Biotinylated Payloads to Myeloid Leukemia Cells.” Scientific Reports, vol. 14, no. 1, Oct. 2024, p. 25080. EBSCOhost, https://doi.org/10.1038/s41598-024-76851-7.

APA

Farokhi-Fard, A., Rahmati, S., Hashemi Aval, N. S., Barkhordari, F., Bayat, E., Komijani, S., Aghamirza Moghim Aliabadi, H., & Davami, F. (2024). Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells. Scientific Reports, 14(1), 25080. https://doi.org/10.1038/s41598-024-76851-7

Chicago

Farokhi-Fard, Aref, Saman Rahmati, Negin Sadat Hashemi Aval, Farzaneh Barkhordari, Elham Bayat, Samira Komijani, Hooman Aghamirza Moghim Aliabadi, and Fatemeh Davami. 2024. “Anti-IL-1RAP ScFv-MSA-S19-TAT Fusion Carrier as a Multifunctional Platform for Versatile Delivery of Biotinylated Payloads to Myeloid Leukemia Cells.” Scientific Reports 14 (1): 25080. doi:10.1038/s41598-024-76851-7.